Nephros (NEPH) Receivables (2010 - 2026)

Nephros' Receivables history runs 17 years deep, the most recent figure standing at $3.5 million for Q1 2026.

• In Q1 2026, Receivables rose 31.53% year-over-year to $3.5 million; the TTM figure through Mar 2026 stood at $3.5 million (up 31.53% YoY), while the FY2025 annual figure was $2.4 million, up 35.54% from the prior year.
• Receivables was $3.5 million for Q1 2026 at Nephros, up from $2.4 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $3.5 million in Q1 2026 to a low of $1.3 million in Q4 2022.
• Historically, Receivables has averaged $1.9 million across 5 years, with a median of $1.8 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Receivables dropped 25.94% in 2023, then jumped 76.35% in 2025.
• A 5-year view of Receivables shows it stood at $1.3 million in 2022, then increased by 16.33% to $1.5 million in 2023, then gained by 19.05% to $1.8 million in 2024, then jumped by 35.54% to $2.4 million in 2025, then surged by 45.86% to $3.5 million in 2026.
• The last three Receivables figures came in at $3.5 million (Q1 2026), $2.4 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.